Key Points
- Healthcare Holding B.V. Gilde sold 1,196 Shoulder Innovations shares at an average price of $22.60, generating $27,029.60. The sale reduced its stake by 0.05%, leaving it with 2.19 million shares valued at approximately $49.4 million.
- Shoulder Innovations shares opened at $21.07, down 0.9%, while the company reported a quarterly loss of $0.49 per share—$0.03 worse than analysts expected—on revenue of $17.18 million.
- Analyst sentiment remains largely positive: five analysts rate the stock a Buy and one rates it Sell, producing a “Moderate Buy” consensus and an average price target of $25.50.
Shoulder Innovations, Inc. (NYSE:SI - Get Free Report) major shareholder Healthcare Holding B.V. Gilde sold 1,196 shares of the firm's stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $22.60, for a total value of $27,029.60. Following the completion of the transaction, the insider owned 2,185,914 shares in the company, valued at approximately $49,401,656.40. This trade represents a 0.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.
Healthcare Holding B.V. Gilde also recently made the following trade(s):
- On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.62, for a total value of $15,404.22.
- On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.61, for a total value of $463,866.76.
- On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total value of $88,140.00.
- On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total transaction of $47,347.00.
- On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.64, for a total transaction of $166,132.32.
- On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total transaction of $2,272,719.24.
- On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.71, for a total transaction of $244,155.21.
- On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.73, for a total transaction of $455,372.82.
- On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.
Shoulder Innovations Stock Down 0.9%
Shares of NYSE SI opened at $21.07 on Friday. The stock has a market cap of $438.68 million and a PE ratio of -10.97. The company has a current ratio of 10.71, a quick ratio of 8.92 and a debt-to-equity ratio of 0.12. Shoulder Innovations, Inc. has a 12-month low of $10.92 and a 12-month high of $24.59. The company has a 50-day moving average of $21.29 and a 200 day moving average of $16.82.
Shoulder Innovations (NYSE:SI - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.49) earnings per share for the quarter, missing analysts' consensus estimates of ($0.46) by ($0.03). The business had revenue of $17.18 million during the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. As a group, sell-side analysts predict that Shoulder Innovations, Inc. will post -1.9 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on SI shares. UBS Group lifted their price objective on Shoulder Innovations from $27.00 to $28.00 and gave the stock a "buy" rating in a research report on Monday, August 10th. BTIG Research raised their target price on Shoulder Innovations from $24.00 to $26.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Piper Sandler reiterated an "overweight" rating and set a $25.00 price target (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. Finally, Weiss Ratings upgraded shares of Shoulder Innovations from a "sell (d-)" rating to a "sell (d)" rating in a research report on Monday, August 3rd. Five analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $25.50.
Read Our Latest Stock Report on SI
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in SI. Rhumbline Advisers purchased a new position in Shoulder Innovations in the third quarter worth approximately $54,000. Vanguard Group Inc. purchased a new stake in Shoulder Innovations in the third quarter valued at $1,836,000. Deerfield Management Company L.P. purchased a new stake in Shoulder Innovations in the third quarter valued at $6,056,000. Bank of America Corp DE acquired a new position in shares of Shoulder Innovations in the 3rd quarter valued at $322,000. Finally, Citadel Advisors LLC acquired a new position in shares of Shoulder Innovations in the 3rd quarter valued at $628,000.
Shoulder Innovations Company Profile
(
Get Free Report)
Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.
In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
